Related Experiment Video
Updated: Apr 21, 2026

09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
17.6K
Functional changes in piriform cortex pyramidal neurons in the chronic methamphetamine-treated rat.
Nobuaki Hori1, Tomoko Kadota, Norio Akaike
1Research Division for Life Sciences, Kumamoto Health Science University, Izumi 325, Kita-ku, Kumamoto City, Kumamoto 861-5598, Japan. nobukun1935@yahoo.co.jp.
General Physiology and Biophysics
|November 5, 2014
Summary
Chronic methamphetamine (MAP) exposure harms rat piriform cortex neurons, impairing synaptic plasticity and potentially causing behavioral issues. This study details MAP
Area of Science:
- Neuroscience
- Neuropharmacology
- Cellular and Molecular Biology
Background:
- Chronic methamphetamine (MAP) administration induces widespread central nervous system (CNS) toxicity in rats.
- The piriform cortex, crucial for sensory processing and learning, serves as a model for synaptic plasticity research.
Purpose of the Study:
- To investigate the effects of chronic MAP treatment on pyramidal neurons in the rat piriform cortex.
- To assess MAP-induced alterations in neuronal function, synaptic plasticity, and morphology.
Main Methods:
- Electrophysiological recordings were used to measure membrane potential, input resistance, and AMPA/NMDA responses in piriform cortical neurons.
- Long-term potentiation (LTP) was assessed to evaluate synaptic plasticity.
- Morphological analysis examined changes in pyramidal neuron dendrites.
Main Results:
- Chronic MAP treatment significantly depolarized neuronal membrane potential and reduced input resistance.
- The voltage-dependence of AMPA and NMDA receptor responses was altered.
- MAP exposure decreased the extent of LTP and caused dendritic blebbing in pyramidal neurons.
Conclusions:
- Chronic MAP treatment detrimentally affects piriform cortical neuron function and synaptic plasticity.
- These neuronal deficits may underlie behavioral impairments observed in MAP-treated animals.
- Synaptic plasticity deficits induced by MAP extend beyond the hippocampus.

